stockrowTakeda Pharmaceutical Co.
TAK Healthcare Drug Manufacturers Specialty & Generic
Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.
- Revenue
- +1.71%
- EPS
- −4.35%
- Free cash flow
- +54.9%
- Total debt
- −7.28%
Quarter to September 2026, against a year earlier
Follow TAK
Alert me
Takeda Pharmaceutical Co. (TAK) Operating cash flow
Takeda Pharmaceutical Co.'s operating cash flow for fiscal 2026 was $6.9B, unchanged from fiscal 2025. Over the twelve months to 30 September 2026 it was $11.6B. Over the past ten years it has ranged from $211.6M (fiscal 2016) to $10.0B (fiscal 2022); the current reading is higher than 67% of that period. Takeda Pharmaceutical Co. ranks 1st of 84 Drug Manufacturers Specialty & Generic companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $6.9B | (1.49%) |
| FY2025 | $7.0B | 41.16% |
| FY2024 | $4.9B | (31.64%) |
| FY2023 | $7.2B | (27.66%) |
| FY2022 | $10.0B | 5.19% |
| FY2021 | $9.5B | 54.22% |
| FY2020 | $6.2B | 108.43% |
| FY2019 | $3.0B | (13.07%) |
| FY2018 | $3.4B | 39.91% |
| FY2017 | $2.4B | 1,048.85% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $1.9B | 138.41% |
| Jun 2026 | $804.0M | (87.21%) |
| Dec 2025 | $6.3B | 146.43% |
| Sep 2025 | $2.6B | 71.58% |
| 26 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| TAK Takeda Pharmaceutical Co. | $11.6B |
| HLN Haleon PLC Sponsored ADR compare | $4.8B |
| ZTS Zoetis Inc. compare | $2.8B |
| VTRS Viatris Inc. compare | $2.5B |
| TEVA Teva Pharmaceutical Industries Ltd. compare | $1.8B |
| UTHR United Therapeutics Corporation compare | $1.4B |
| NBIX Neurocrine Biosciences, Inc. compare | $1.1B |
| ELAN Elanco Animal Health Incorporated compare | $617.0M |
| RDY Dr. Reddy's Laboratories Ltd compare | $313.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on TAK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement